Free Trial
→ I'm handing you this one free (From Behind the Markets) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CoreWeave Inc. stock logo
CRWV
CoreWeave
$60.77
+24.7%		$74.13
$40.58
▼
$138.25
$27.89B7.7133.06 million shs160.68 million shs
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
$433.03
+0.1%		$482.58
$353.54
▼
$615.00
$10.06B-0.98354,099 shs296,515 shs
The Best Nuclear Energy Stocks to Buy Cover
The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CoreWeave Inc. stock logo
CRWV
CoreWeave
-0.51%-9.32%-40.63%-54.77%-53.86%
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
-0.04%+9.15%-8.30%-19.32%-12.76%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CoreWeave Inc. stock logo
CRWV
CoreWeave
$60.77
+24.7%		$74.13
$40.58
▼
$138.25
$27.89B7.7133.06 million shs160.68 million shs
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
$433.03
+0.1%		$482.58
$353.54
▼
$615.00
$10.06B-0.98354,099 shs296,515 shs
The Best Nuclear Energy Stocks to Buy Cover
The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CoreWeave Inc. stock logo
CRWV
CoreWeave
-0.51%-9.32%-40.63%-54.77%-53.86%
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
-0.04%+9.15%-8.30%-19.32%-12.76%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CoreWeave Inc. stock logo
CRWV
CoreWeave
2.59
Moderate Buy$118.6995.32% Upside
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
2.82
Moderate Buy$706.8763.24% Upside

Current Analyst Ratings Breakdown

Latest CRWV and MDGL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/11/2026
CoreWeave Inc. stock logo
CRWV
CoreWeave
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price Target$68.00
11/11/2026
CoreWeave Inc. stock logo
CRWV
CoreWeave
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$128.00 ➝ $149.00
11/11/2026
CoreWeave Inc. stock logo
CRWV
CoreWeave
DA Davidson logo
DA Davidson
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetNeutral$100.00 ➝ $45.00
11/11/2026
CoreWeave Inc. stock logo
CRWV
CoreWeave
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$165.00 ➝ $115.00
11/11/2026
CoreWeave Inc. stock logo
CRWV
CoreWeave
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetOverweight$176.00 ➝ $100.00
11/11/2026
CoreWeave Inc. stock logo
CRWV
CoreWeave
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetHold$120.00 ➝ $60.00
11/11/2026
CoreWeave Inc. stock logo
CRWV
CoreWeave
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingHold
11/9/2026
CoreWeave Inc. stock logo
CRWV
CoreWeave
Rosenblatt Securities logo
Rosenblatt Securities
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$250.00 ➝ $160.00
11/9/2026
CoreWeave Inc. stock logo
CRWV
CoreWeave
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetOverweight$160.00 ➝ $115.00
11/4/2026
CoreWeave Inc. stock logo
CRWV
CoreWeave
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$159.00 ➝ $128.00
11/4/2026
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access to unlock brokerage rankings
Initiated CoverageStrong-Buy
(Data available from 11/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CoreWeave Inc. stock logo
CRWV
CoreWeave
$7.59B3.67$4.65 per share13.08$8.63 per share7.04
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
$1.43B7.04N/AN/A$26.99 per share16.04
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CoreWeave Inc. stock logo
CRWV
CoreWeave
-$1.17B-$3.65N/AN/AN/A-25.41%-47.95%-3.79%N/A
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
-$288.28M-$5.98N/A59.32N/A-10.89%-27.08%-12.04%N/A

Latest CRWV and MDGL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/3/2026Q3 2026
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
-$1.09$1.83+$2.92$1.83$404.17 million$431.27 million
8/11/2026Q2 2026
CoreWeave Inc. stock logo
CRWV
CoreWeave
-$1.52-$1.14+$0.38-$1.14N/A$2.58 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CoreWeave Inc. stock logo
CRWV
CoreWeave
N/AN/AN/AN/AN/A
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CoreWeave Inc. stock logo
CRWV
CoreWeave
5.53
0.46
0.46
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
0.54
3.05
2.78

Institutional Ownership

CompanyInstitutional Ownership
CoreWeave Inc. stock logo
CRWV
CoreWeave
N/A
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
98.50%

Insider Ownership

CompanyInsider Ownership
CoreWeave Inc. stock logo
CRWV
CoreWeave
24.20%
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
17.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
CoreWeave Inc. stock logo
CRWV
CoreWeave
2,189458.87 million347.83 millionOptionable
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
91523.23 million19.14 millionOptionable

Recent News About These Companies

Kaplan Fox Encourages Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Investors to Contact the Firm Regarding an Investigation of Possible Securities Law Violations
November 11 at 1:35 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/11/11/3401064/1020/en/kaplan-fox-encourages-madrigal-pharmaceuticals-inc-nasdaq-mdgl-investors-to-contact-the-firm-regarding-an-investigation-of-possible-securities-law-violations.html
Kaplan Fox Encourages Investors of Madrigal Pharmaceuticals, Inc. (MDGL) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation
November 11 at 5:00 AM  |  newsfilecorp.comN
Kaplan Fox Encourages Investors of Madrigal Pharmaceuticals, Inc. (MDGL) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation
November 11 at 4:50 AM  |  newsfilecorp.comN
Madrigal Pharmaceuticals stock faces scrutiny over data allegations
November 10 at 8:32 PM  |  ad-hoc-news.deA
Kaplan Fox Notifies Investors of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) of an Investigation Into Potential Securities Law Violations
November 10 at 8:32 PM  |  newmediawire.comN
NASDAQ: MDGL Investigation: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP
November 10 at 3:31 PM  |  financialcontent.comF
Kaplan Fox is Investigating Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) for Potential Securities Law Violations Investors are Encouraged to Contact the Firm
November 10 at 3:31 PM  |  financialcontent.comF
MDGL INVESTIGATION NOTICE: Hagens Berman, National Securities Law Firm, Investigating Madrigal Pharmaceuticals (NASDAQ: MDGL) Following Whistleblower Allegations of Clinical Data Integrity Concerns
November 10 at 2:49 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/11/10/3400141/32716/en/mdgl-investigation-notice-hagens-berman-national-securities-law-firm-investigating-madrigal-pharmaceuticals-nasdaq-mdgl-following-whistleblower-allegations-of-clinical-data-integri.html
4 Commercial-Stage Biotechs Poised for Sustained Revenue Growth
November 10 at 10:16 AM  |  zacks.comhttps://www.zacks.com/stock/news/3027110/4-commercial-stage-biotechs-poised-for-sustained-revenue-growth?cid=cs-stocknewsapi-ft-analyst_blog|investment_ideas-3027110
Madrigal Pharmaceuticals, Inc. $MDGL Stock Position Reduced by Pictet Asset Management Holding SA
November 10 at 5:15 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-madrigal-pharmaceuticals-inc-mdgl-stock-position-reduced-by-pictet-asset-management-holding-sa-2026-11-10/
Kaplan Fox Alerts Madrigal Pharmaceuticals, Inc. (MDGL) Investors to an Investigation of Potential Securities Law Violations
November 10 at 4:35 AM  |  newsfilecorp.comN
Kaplan Fox Encourages Investors of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) to Contact the Firm Regarding an Investigation Into Possible Securities Law Violations
November 9 at 7:18 PM  |  newmediawire.comN
Kaplan Fox Alerts Investors of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) to an Ongoing Investigation of Possible Securities Law Violations
November 9 at 1:20 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/11/09/3398871/1020/en/kaplan-fox-alerts-investors-of-madrigal-pharmaceuticals-inc-nasdaq-mdgl-to-an-ongoing-investigation-of-possible-securities-law-violations.html
Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) General Counsel Sells $430,800.00 in Stock
November 9 at 4:23 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31188399
Kaplan Fox Announces a Securities Investigation into Madrigal Pharmaceuticals, Inc. (MDGL) - Investors Encouraged to Contact the Firm
November 9 at 4:20 AM  |  newsfilecorp.comN
Madrigal Pharmaceuticals, Inc. $MDGL Stock Position Lessened by Candriam S.C.A.
November 9 at 4:03 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-madrigal-pharmaceuticals-inc-mdgl-stock-position-lessened-by-candriam-sca-2026-11-09/
MDGL Investors Have Opportunity to Join Madrigal Pharmaceuticals, Inc. Fraud Investigation with SBS Law
November 8 at 12:00 AM  |  businesswire.comhttps://www.businesswire.com/news/home/20261108871205/en/MDGL-Investors-Have-Opportunity-to-Join-Madrigal-Pharmaceuticals-Inc.-Fraud-Investigation-with-SBS-Law/
Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock: Insider Bros. Advisors Lp Baker Acquires 15,666 Shares
November 8 at 4:09 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31186378
What is HC Wainwright's Forecast for MDGL FY2026 Earnings?
November 8 at 2:01 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31185170
MDGL Investigation Reminder: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP
November 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/11/07/3397975/0/en/mdgl-investigation-reminder-madrigal-pharmaceuticals-inc-investors-are-encouraged-to-contact-kessler-topaz-meltzer-check-llp.html
Madrigal Pharmaceuticals (NASDAQ:MDGL) General Counsel Sells $430,800.00 in Stock
November 7, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-mdgl-insider-buying-and-selling-2026-11-07/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
White Tesla sports car parked at a launch site with rocket boosters visible against a sunset sky.
Tesla's Roadster Reveal Hints at 2 Much Bigger Moves
By Sam Quirke | October 19, 2026
Salesforce cloud logo in a futuristic tech setting, highlighting CRM enterprise software and AI platform growth.
Salesforce Fuels AI Engine With $5.66B Braze Buyout
By Jeffrey Neal Johnson | October 21, 2026
Bronze bull and bear statues face off in an urban financial district at sunset.
MarketBeat Week in Review – 10/19 - 10/23
By MarketBeat Staff | October 24, 2026
Office desk overlooking a city skyline at dusk, with a computer monitor displaying a declining red stock price chart.
Insiders Are Selling These 5 AI Stocks—Should You Worry?
By Thomas Hughes | October 26, 2026
CoreWeave logo displayed above a server data center illustration with glowing blue network connections and a globe.
Wired for Upside: Why Goldman Sachs Upgraded CoreWeave's Battered Stock
By Jeffrey Neal Johnson | October 20, 2026
CoreWeave stock logo

CoreWeave NASDAQ:CRWV

$60.77 +12.04 (+24.71%)
Closing price 04:00 PM Eastern
Extended Trading
$56.49 -4.28 (-7.04%)
As of 06:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

Madrigal Pharmaceuticals stock logo

Madrigal Pharmaceuticals NASDAQ:MDGL

$433.03 +0.43 (+0.10%)
Closing price 04:00 PM Eastern
Extended Trading
$432.74 -0.29 (-0.07%)
As of 06:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas